Get PT-141 (Bremelanotide) Online in Connecticut | OmniRx Health
Sexual Wellness Treatment in Connecticut
PT-141 (Bremelanotide) is a melanocortin receptor agonist that enhances sexual desire and arousal through the central nervous system — not the vascular system. It is the first non-hormonal treatment for hypoactive sexual desire disorder approved by the FDA.
Key Benefits
- Works through the brain to enhance desire and arousal
- Effective for both men and women
- Addresses root causes of low libido rather than just physical response
- FDA-approved active ingredient (Vyleesi for women)
- Unique central mechanism distinct from PDE5 inhibitors
Who is a Good Candidate?
Men and women experiencing low sexual desire (HSDD), reduced libido, or sexual arousal difficulties who want a centrally-acting treatment that addresses desire rather than just the physical mechanics of sexual function.
Starting from $199/month
Serving Connecticut
From the corporate corridors of Stamford to the historic streets of New Haven, Connecticut residents lead busy lives that demand flexible healthcare. OmniRx Health serves the entire Constitution State—whether you're commuting to NYC for work, studying at Yale, or enjoying retirement along the Connecticut shoreline. Our telehealth services bring expert medical care directly to you, saving precious time in one of America's most fast-paced regions.
OmniRx Health providers are licensed by the Connecticut Medical Examining Board to deliver telehealth throughout the state.
Partner pharmacies across Hartford, New Haven, Stamford, and throughout Connecticut ensure quick prescription fulfillment and delivery.
Connecticut requires insurers to cover telehealth services and has expanded virtual care access with permanent legislation supporting remote healthcare delivery.
Connecticut mandates insurance coverage for telehealth at parity with in-person visits, making virtual care accessible and affordable for most residents.
Frequently Asked Questions
- How does PT-141 work differently from Viagra or Cialis?
- PDE5 inhibitors like sildenafil and tadalafil work by increasing blood flow to the genitals — they improve physical erectile function but do not enhance sexual desire. PT-141 activates melanocortin receptors in the brain that regulate sexual motivation and arousal, addressing the psychological and neurological dimension of sexual response that PDE5 inhibitors do not target.
- Can women use PT-141?
- Yes. PT-141 was originally developed in part to address hypoactive sexual desire disorder (HSDD) in women. Vyleesi (bremelanotide injection) is FDA-approved for premenopausal women with HSDD. It has also demonstrated benefits in men with situational erectile dysfunction related to low desire or performance anxiety.
- How and when is PT-141 administered?
- PT-141 is administered as a subcutaneous injection, typically 45 minutes to 2 hours before anticipated sexual activity to allow sufficient time for central nervous system activation. The injection site is typically the abdomen. Nausea is the most commonly reported side effect and is usually mild and temporary.
- Is telehealth legal in Connecticut?
- Yes, Connecticut has robust telehealth laws that fully support virtual healthcare. Licensed providers can offer consultations, diagnose conditions, and prescribe medications through secure video platforms.
- Can Connecticut residents get prescriptions via telehealth?
- Yes, Connecticut allows telehealth providers to prescribe medications following a proper virtual evaluation. Prescriptions are sent to your preferred local pharmacy or can be delivered to your home.
- Does Connecticut insurance cover telehealth visits?
- Connecticut law requires health insurers to cover telehealth services at the same rate as in-person appointments. Most commercial plans, as well as HUSKY Health (Medicaid), cover virtual visits.